Response to ‘Comment on ‘Measuring the impact of medicines regulatory interventions - systematic review and methodological considerations’ by Goedecke et al .’-Reference-Cited by-同舟云学术

Response to ‘Comment on ‘Measuring the impact of medicines regulatory interventions - systematic review and methodological considerations’ by Goedecke et al .’

Published:2018-07-03 Issue:9 Volume:84 Page:2169-2170
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:Br J Clin Pharmacol

Author:

Goedecke Thomas¹^ORCID,Morales Daniel R.¹²^ORCID,Pacurariu Alexandra¹,Kurz Xavier¹

Affiliation:

1. Pharmacovigilance and Epidemiology Department, Inspections Human Medicines Pharmacovigilance and Committees Division; European Medicines Agency (EMA); London E14 5EU UK

2. Division of Population Health Sciences; University of Dundee; Dundee DD2 4BF UK

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bcp.13664/fullpdf

Reference3 articles.

1. Comment on ‘Measuring the impact of medicines regulatory interventions - systematic review and methodological considerations’ by Goedecke et al;Lu;Br J Clin Pharmacol,2018

2. Measuring the impact of medicines regulatory interventions - systematic review and methodological considerations;Goedecke;Br J Clin Pharmacol,2018

3. Changes in antidepressant use by young people and suicidal behavior after FDA warnings and media coverage: quasi-experimental study;Lu;BMJ,2014

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Navigating stormy waters: 10 years of operation of the European Union Regulatory Network Incident Management Plan for Medicines for Human Use;Pharmacoepidemiology and Drug Safety;2020-09-21